252 related articles for article (PubMed ID: 16439401)
1. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
[TBL] [Abstract][Full Text] [Related]
2. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
[TBL] [Abstract][Full Text] [Related]
3. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
Kerr T; Small W; Moore D; Wood E
Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
[TBL] [Abstract][Full Text] [Related]
4. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility.
Kerr T; Tyndall MW; Zhang R; Lai C; Montaner JS; Wood E
Am J Public Health; 2007 Jul; 97(7):1228-30. PubMed ID: 17538061
[TBL] [Abstract][Full Text] [Related]
5. Rationale for evaluating North America's first medically supervised safer-injecting facility.
Wood E; Kerr T; Montaner JS; Strathdee SA; Wodak A; Hankins CA; Schechter MT; Tyndall MW
Lancet Infect Dis; 2004 May; 4(5):301-6. PubMed ID: 15120347
[TBL] [Abstract][Full Text] [Related]
6. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
Wood E; Tyndall MW; Montaner JS; Kerr T
CMAJ; 2006 Nov; 175(11):1399-404. PubMed ID: 17116909
[TBL] [Abstract][Full Text] [Related]
7. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
[TBL] [Abstract][Full Text] [Related]
8. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
[TBL] [Abstract][Full Text] [Related]
9. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
[TBL] [Abstract][Full Text] [Related]
10. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
[TBL] [Abstract][Full Text] [Related]
11. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
[TBL] [Abstract][Full Text] [Related]
12. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.
Small W; Shoveller J; Moore D; Tyndall M; Wood E; Kerr T
Qual Health Res; 2011 Jun; 21(6):743-56. PubMed ID: 21378259
[TBL] [Abstract][Full Text] [Related]
13. [The initial experience in supervised injecting facilities in Denmark].
Axelsson A; Hvam F; Bonde M; Olsen ML; Kiørboe E; Hoff-Lund O; Abildgaard M; Iversen K
Ugeskr Laeger; 2012 Sep; 174(39):2286-9. PubMed ID: 23006221
[TBL] [Abstract][Full Text] [Related]
14. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
[TBL] [Abstract][Full Text] [Related]
15. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
[TBL] [Abstract][Full Text] [Related]
16. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.
Wood E; Tyndall MW; Qui Z; Zhang R; Montaner JS; Kerr T
Am J Public Health; 2006 May; 96(5):770-3. PubMed ID: 16571703
[TBL] [Abstract][Full Text] [Related]
17. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.
Kerr T; Wood E; Small D; Palepu A; Tyndall MW
CMAJ; 2003 Oct; 169(8):759-63. PubMed ID: 14557313
[TBL] [Abstract][Full Text] [Related]
18. Access to health and social services for IDU: the impact of a medically supervised injection facility.
Small W; Van Borek N; Fairbairn N; Wood E; Kerr T
Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786
[TBL] [Abstract][Full Text] [Related]
19. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.
Wood E; Kerr T; Small W; Li K; Marsh DC; Montaner JS; Tyndall MW
CMAJ; 2004 Sep; 171(7):731-4. PubMed ID: 15451834
[TBL] [Abstract][Full Text] [Related]
20. Do supervised injecting facilities attract higher-risk injection drug users?
Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
